These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 21474279)

  • 41. Cluster randomized trials produced similar results to individually randomized trials in a meta-analysis of enhanced care for depression.
    Gilbody S; Bower P; Torgerson D; Richards D
    J Clin Epidemiol; 2008 Feb; 61(2):160-168. PubMed ID: 18177789
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study.
    Wood L; Egger M; Gluud LL; Schulz KF; Jüni P; Altman DG; Gluud C; Martin RM; Wood AJ; Sterne JA
    BMJ; 2008 Mar; 336(7644):601-5. PubMed ID: 18316340
    [TBL] [Abstract][Full Text] [Related]  

  • 43. No consistent evidence of data availability bias existed in recent individual participant data meta-analyses: a meta-epidemiological study.
    Tsujimoto Y; Fujii T; Onishi A; Omae K; Luo Y; Imai H; Takahashi S; Itaya T; Pinson C; Nevitt SJ; Furukawa TA
    J Clin Epidemiol; 2020 Feb; 118():107-114.e5. PubMed ID: 31654789
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Assessing allocation concealment and blinding in randomized controlled trials: why bother?
    Schulz KF
    ACP J Club; 2000; 132(2):A11-2. PubMed ID: 10750446
    [No Abstract]   [Full Text] [Related]  

  • 45. Balancing treatment allocations by clinician or center in randomized trials allows unacceptable levels of treatment prediction.
    Hills RK; Gray R; Wheatley K
    J Evid Based Med; 2009 Aug; 2(3):196-204. PubMed ID: 21349013
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Studywise minimization: a treatment allocation method that improves balance among treatment groups and makes allocation unpredictable.
    Perry M; Faes M; Reelick MF; Olde Rikkert MG; Borm GF
    J Clin Epidemiol; 2010 Oct; 63(10):1118-22. PubMed ID: 20304606
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Randomization. Part 3: allocation concealment and randomization implementation.
    Pandis N
    Am J Orthod Dentofacial Orthop; 2012 Jan; 141(1):126-8. PubMed ID: 22196195
    [No Abstract]   [Full Text] [Related]  

  • 48. Association Between Risk-of-Bias Assessments and Results of Randomized Trials in Cochrane Reviews: The ROBES Meta-Epidemiologic Study.
    Savovic J; Turner RM; Mawdsley D; Jones HE; Beynon R; Higgins JPT; Sterne JAC
    Am J Epidemiol; 2018 May; 187(5):1113-1122. PubMed ID: 29126260
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Reported methodologic quality and discrepancies between large and small randomized trials in meta-analyses.
    Kjaergard LL; Villumsen J; Gluud C
    Ann Intern Med; 2001 Dec; 135(11):982-9. PubMed ID: 11730399
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Selection bias, allocation concealment and randomization design in clinical trials.
    Zhao W
    Contemp Clin Trials; 2013 Sep; 36(1):263-5. PubMed ID: 23871796
    [No Abstract]   [Full Text] [Related]  

  • 51. In search of justification for the unpredictability paradox.
    Howick J; Mebius A
    Trials; 2014 Dec; 15():480. PubMed ID: 25490908
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Impact of blinding on estimated treatment effects in randomised clinical trials: meta-epidemiological study.
    Moustgaard H; Clayton GL; Jones HE; Boutron I; Jørgensen L; Laursen DRT; Olsen MF; Paludan-Müller A; Ravaud P; Savović J; Sterne JAC; Higgins JPT; Hróbjartsson A
    BMJ; 2020 Jan; 368():l6802. PubMed ID: 31964641
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Allocation concealment in randomised trials: defending against deciphering.
    Schulz KF; Grimes DA
    Lancet; 2002 Feb; 359(9306):614-8. PubMed ID: 11867132
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Bias in identifying and recruiting participants in cluster randomised trials: what can be done?
    Eldridge S; Kerry S; Torgerson DJ
    BMJ; 2009 Oct; 339():b4006. PubMed ID: 19819928
    [No Abstract]   [Full Text] [Related]  

  • 55. No evidence for intervention-dependent influence of methodological features on treatment effect.
    Jacobs WC; Kruyt MC; Moojen WA; Verbout AJ; Oner FC
    J Clin Epidemiol; 2013 Dec; 66(12):1347-55.e3. PubMed ID: 24018348
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Allocation concealment in clinical trials.
    Schulz KF; Altman DG; Moher D
    JAMA; 2002 Nov; 288(19):2406-7; author reply 2408-9. PubMed ID: 12435253
    [No Abstract]   [Full Text] [Related]  

  • 57. Allocation concealment in RCTs.
    El-Masri MM
    Can Nurse; 2014 Nov; 110(8):10. PubMed ID: 25536693
    [No Abstract]   [Full Text] [Related]  

  • 58. Expansion of the modified Zelen's approach randomization and dynamic randomization with partial block supplies at the centers to unequal allocation.
    Kuznetsova OM; Tymofyeyev Y
    Contemp Clin Trials; 2011 Nov; 32(6):962-72. PubMed ID: 21888990
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Influence of reported study design characteristics on intervention effect estimates from randomized, controlled trials.
    Savović J; Jones HE; Altman DG; Harris RJ; Jüni P; Pildal J; Als-Nielsen B; Balk EM; Gluud C; Gluud LL; Ioannidis JP; Schulz KF; Beynon R; Welton NJ; Wood L; Moher D; Deeks JJ; Sterne JA
    Ann Intern Med; 2012 Sep; 157(6):429-38. PubMed ID: 22945832
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Bias and small-study effects influence treatment effect estimates: a meta-epidemiological study in oral medicine.
    Papageorgiou SN; Antonoglou GN; Tsiranidou E; Jepsen S; Jäger A
    J Clin Epidemiol; 2014 Sep; 67(9):984-92. PubMed ID: 24855929
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.